Medico Remedies Pays Fines Imposed by NSE and BSE Over Compliance Regulation
Medico Remedies Limited has settled penalties levied by both the National Stock Exchange of India (NSE) and BSE regarding alleged non-compliance with certain regulations. The company paid the requisite fines on May 25, 2026, following the receipt of penalty notices from the stock exchanges.The regulatory action arose from an alleged non-compliance concerning Regulation 6(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company received the relevant SoP Notices from both NSE and BSE on May 20, 2026.
Each stock exchange had levied a penalty amounting to Rs. 56,640/-, inclusive of GST. The company successfully cleared the dues with both exchanges on the subsequent day.
A summary of the violation details is provided below:
| Particulars | Details |
|---|---|
| Regulatory Authority | NSE and BSE |
| Date of Notice Receipt | May 20, 2026 |
| Alleged Non-Compliance | Regulation 6(1) of the Listing Regulations |
| Penalty Amount (per exchange) | Rs. 56,640/– (inclusive of GST) |
| Action Taken | Requisite SoP fines paid on May 25, 2026 |
Regarding the consequences of this matter, Medico Remedies Limited stated that there is no material impact on its financial status or operational activities. The company confirmed that it achieved compliance with Regulation 6(1) of the SEBI (LODR) Regulations, 2015, effective from February 18, 2026.
The company acknowledged an inadvertent delay in the submission of the required intimation but committed to ensuring that such unintended failures do not recur in the future.
MEDICO Stock Price Movement
Shares of Medico Remedies Limited slipped by 2.17% on Wednesday, settling at ₹46.36 after trading in a narrow intraday range between a low of ₹46.11 and a high of ₹47.81. The equity saw a traded volume of 83,203 shares during the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.